In the SCOT-HEART 2 trial, we will recruit at least 6,000 people from Scotland who are at risk of heart disease and will compare two ways of deciding how to prevent future heart problems. We will compare the current standard of care, using a Scottish ‘risk score’, with a CTCA scan to look at the heart. This will help us find out if making decisions based on the results of a CTCA will stop too many people being given medicines they don’t really need, and see whether it lowers the number of people developing heart disease.
Chief Investigator: Prof David Newby
Number and location of participating sites / geographical scope (by region/country): Western General Hospital Edinburgh (Recruitment), Royal Infirmary Edinburgh (Scanning)
Funder: British Heart Foundation
Start and End date
Of grant award: 01 April 2019 - 01 April 2027
Of recruitment: 13 January 2020
Current Status: Open
Trial website - The SCOT-HEART 2 Trial
Sponsor: ACCORD http://www.accord.ed.ac.uk/
Chief Investigator: Professor David Newby, Centre of Cardiovascular Science, Chancellor's Building, 49 Little France Crescent, Edinburgh, EH16 4SB
Trial Manager: Edinburgh Clinical Trials Unit, Usher Institute, University of Edinburgh, Edinburgh BioQuarter, 5-7 Little France Road, Edinburgh EH16 4UX Email: SCOT.HEART2@ed.ac.uk
UK GDPR Privacy Statement: Information can be found in our Participant Information Sheets.
You can find out more about how we use your information
• By asking one of the research team
• By contacting a Data Protection Officer
University of Edinburgh Data Protection Officer Governance and Strategic Planning University of Edinburgh Old College Edinburgh EH8 9YL Tel: 0131 651 4114 | NHS Lothian Data Protection Officer NHS Lothian Waverley Gate 2-4 Waterloo Place Edinburgh EH1 3EG Tel: 0131 465 5444 |
ECTU Involvement: Trial Management / Database / Data Management / Admin support / Health Economics
(UKCRC)